NHF’s QMS is ISO – 9001:2015 Certified · Government of Jamaica

An agency of the Ministry of Health & Wellness

NEW DRUG TO TREAT RHEUMATOID ARTHRITIS ADDED TO NHF DRUG LIST

NEW DRUG TO TREAT RHEUMATOID ARTHRITIS ADDED TO NHF DRUG LIST

The active ingredient Leflunomide (Arava) that is used to treat rheumatoid arthritis has been added to the National Health Fund, NHF Drug List effective May 2, 2008. The NHF subsidy for each 20 milligram tablet is $200.93.This brings the total number of active ingredients on the NHF Drug List to 189.

Other changes to the NHF Drug List effective May 1, 2008 include the addition of five new generic drugs for existing active ingredients. These are Intaxel (Paclitaxel) injection used in the treatment of prostate cancer, with subsidies of $31,824 for the 300mg/50 millilitre injection and $3,182.40 for the 30mg/5 millilitre injection; Fivoflu (Fluorouracil) 500mg/10 millilitre injection which is used for the treatment of breast cancer with a subsidy of $219.56; Zexate (Methotrexate) 25 millilitre injection used for treating rheumatoid arthritis and breast cancer, with a subsidy of $122.58; Diclomax (Diclofenac) 50mg tablets with a subsidy of $6.05 per tablet and Clopidogrel-Health 2000 75 milligram tablets with a subsidy of $47.49 per tablet.

In addition effective May 1, 2008 the severe limit for Atorvastatin (Lipitor) has been increased from 40 milligrams to 80 milligrams per day. Beneficiaries enrolling for the NHFCard must have their doctor indicate whether they are suffering from a mild or severe form of a chronic illness covered by the NHF. This designation will determine the strength of medication that will be authorized for them when they use their NHFCard to fill their prescription. Atorvastatin (Lipitor) is used in the treatment of high cholesterol.

Beneficiaries whose condition move from mild to severe or who develop a new chronic condition covered by the NHF, after initial enrolment must have their doctor complete a change form and submit to the NHF. On receipt of the form, the NHF will update the beneficiary’s information. Once this is complete the beneficiary is not issued a new NHFCard but continues to use the existing NHFcard, to access medication for the new condition or for authorization of increased medication for the severe form of the disease.

An agency of the Ministry of Health & Wellness
NHF’s QMS is ISO – 9001:2015 Certified

National Health Fund The Towers,
6th Floor 25 Dominica Drive,
Kingston 5

(876) 906-1106 / (876) 906-4381

1-888-DIAL-NHF (342-5643)

[email protected]

National Health Fund © 2024. All Rights Reserved.